Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 3 |
2019 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A proteomic analysis of an in vitro knock-out of miR-200c.
Sci Rep. 2018 May 2;8(1):6927. doi: 10.1038/s41598-018-25240-y.
Sci Rep. 2018.
PMID: 29720730
Free PMC article.
Combating Drug Resistance by Exploiting miRNA-200c-Controlled Phase II Detoxification.
Köhler B, Dubovik S, Hörterer E, Wilk U, Stöckl JB, Tekarslan-Sahin H, Ljepoja B, Paulitschke P, Fröhlich T, Wagner E, Roidl A.
Köhler B, et al. Among authors: ljepoja b.
Cancers (Basel). 2022 Nov 11;14(22):5554. doi: 10.3390/cancers14225554.
Cancers (Basel). 2022.
PMID: 36428646
Free PMC article.
Item in Clipboard
Downregulation of GRK5 hampers the migration of breast cancer cells.
Sommer AK, Falcenberg M, Ljepoja B, Fröhlich T, Arnold GJ, Wagner E, Roidl A.
Sommer AK, et al. Among authors: ljepoja b.
Sci Rep. 2019 Oct 29;9(1):15548. doi: 10.1038/s41598-019-51923-1.
Sci Rep. 2019.
PMID: 31664083
Free PMC article.
Item in Clipboard
Inducible microRNA-200c decreases motility of breast cancer cells and reduces filamin A.
Ljepoja B, Schreiber C, Gegenfurtner FA, García-Roman J, Köhler B, Zahler S, Rädler JO, Wagner E, Roidl A.
Ljepoja B, et al.
PLoS One. 2019 Nov 20;14(11):e0224314. doi: 10.1371/journal.pone.0224314. eCollection 2019.
PLoS One. 2019.
PMID: 31747409
Free PMC article.
Item in Clipboard
MiRNA-27a sensitizes breast cancer cells to treatment with Selective Estrogen Receptor Modulators.
Ljepoja B, García-Roman J, Sommer AK, Wagner E, Roidl A.
Ljepoja B, et al.
Breast. 2019 Feb;43:31-38. doi: 10.1016/j.breast.2018.10.007. Epub 2018 Oct 18.
Breast. 2019.
PMID: 30415143
Item in Clipboard
A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells.
Sommer AK, Hermawan A, Ljepoja B, Fröhlich T, Arnold GJ, Wagner E, Roidl A.
Sommer AK, et al. Among authors: ljepoja b.
Int J Mol Med. 2018 Oct;42(4):1987-1997. doi: 10.3892/ijmm.2018.3781. Epub 2018 Jul 18.
Int J Mol Med. 2018.
PMID: 30066829
Free PMC article.
Item in Clipboard
Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases.
Sommer AK, Hermawan A, Mickler FM, Ljepoja B, Knyazev P, Bräuchle C, Ullrich A, Wagner E, Roidl A.
Sommer AK, et al. Among authors: ljepoja b.
Oncotarget. 2016 Aug 2;7(31):50461-50476. doi: 10.18632/oncotarget.10459.
Oncotarget. 2016.
PMID: 27409163
Free PMC article.
Item in Clipboard
Cite
Cite